Related Experiment Videos
Dysfunction of the thymus in mice with hypertension
Xianliang Dai1, Shuaibo Huang1, Zhiqing He1
1Department of Cardiology, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China.
Experimental and Therapeutic Medicine
|April 18, 2017
Summary
Hypertension in mice impairs thymus function, indicated by reduced Forkhead box protein N1 (Foxn1) and autoimmune regulator (AIRE) mRNA levels. This suggests the thymus may be a new therapeutic target for hypertension treatment.
Area of Science:
- Immunology
- Cardiovascular Science
- Molecular Biology
Background:
- Hypertension is a prevalent cardiovascular condition with complex pathophysiology.
- The thymus plays a critical role in T cell development and immune system regulation.
- Potential links between immune dysfunction and hypertension are increasingly recognized.
Purpose of the Study:
- To investigate the impact of hypertension on thymus function in a mouse model.
- To evaluate the expression of key thymus-related genes and T cell subset populations in hypertensive mice.
Main Methods:
- Utilized a two-kidney, one-clip (2K1C) rodent model of hypertension.
- Assessed mRNA levels of Forkhead box protein N1 (Foxn1) and autoimmune regulator (AIRE) via RT-qPCR.
- Analyzed signal-joint T cell receptor excision circles (sjTRECs) and T cell subsets.
Main Results:
- Hypertension significantly reduced thymus mRNA levels of Foxn1 and AIRE at 4 and 8 weeks post-surgery.
- A transient decrease in Foxn1 and AIRE was observed in sham-operated mice, with subsequent recovery.
- Similar reductions were noted in sjTRECs and T cell subsets in hypertensive mice.
Conclusions:
- Impaired thymus function is demonstrably associated with hypertension in mice.
- These findings highlight the thymus as a potential novel therapeutic target for hypertension management.